Akzo Nobel (AKZA) M&A Announcement summary
Event summary combining transcript, slides, and related documents.
M&A Announcement summary
9 Jul, 2026Deal rationale and strategic fit
Merger creates a global coatings leader with $17B in revenue and $25B enterprise value, combining complementary portfolios, expanding geographic reach to 160+ countries, and leveraging globally recognized brands.
Positions the combined entity as the #2 global coatings company, with diversified portfolios, enhanced commercial reach, and leading positions across key end-markets.
Enhanced innovation capabilities and sustainability-driven solutions underpin growth and customer value, supported by $400M annual R&D spend and 91 global R&D centers.
Shared values, heritage, and aligned leadership form a strong platform for sustainable growth and customer service.
Financial terms and conditions
All-stock merger of equals; Axalta shareholders receive 0.6539 AkzoNobel shares for each Axalta share.
AkzoNobel to pay a special cash dividend to its shareholders equal to €2.5B minus 2026 regular dividends prior to completion.
Pro forma ownership: AkzoNobel shareholders 55%, Axalta shareholders 45%.
Combined company will be listed on the NYSE, domiciled in the Netherlands, with dual headquarters in Amsterdam and Philadelphia.
Target net leverage ratio of 2.0x–2.5x and commitment to investment grade credit rating.
Synergies and expected cost savings
Identified run-rate synergies of $600M, with 90% expected within three years post-close.
Synergies primarily from SG&A (45%), procurement (28%), footprint optimization (17%), and supply chain (10%).
Synergy estimates are based on detailed, bottom-up analysis and are considered highly executable.
Total costs to achieve synergies estimated at ~$600M, mostly incurred in the first two years.
Revenue synergies are anticipated but not included in the financial model; cost synergies are mechanical and reliable.
Latest events from Akzo Nobel
- Q2 2026 saw 2% organic sales growth, margin expansion, and strong merger progress.AKZA
Q2 202622 Jul 2026 - Q3 EBITDA margin rose to 15.1%, free cash flow improved, and a €300m legal provision was booked.AKZA
Q3 20258 Jul 2026 - Strong results, merger plans, and all proposals approved amid governance and remuneration debate.AKZA
AGM 20269 May 2026 - Adjusted EBITDA margin rose to 14.5% despite revenue decline; Deco and Asia drove growth.AKZA
Q1 202623 Apr 2026 - Flat sales, margin gains, and India divestment set stage for Axalta merger and future growth.AKZA
Q4 20253 Feb 2026 - Q2 2024 saw 2% organic sales growth, stable EBITDA, and strong Performance Coatings results.AKZA
Q2 20243 Feb 2026 - Q3 2024 delivered 1% organic growth, margin gains, and ongoing cost actions amid FX headwinds.AKZA
Q3 202419 Jan 2026 - Adjusted EBITDA rose 3% to €1.5 billion, with 2025 guidance set above €1.55 billion.AKZA
Q4 20249 Jan 2026 - Q1 EBITDA held at €357m as cost actions offset lower volumes; 2025 guidance reaffirmed.AKZA
Q1 202521 Dec 2025